Sign in
Persistent placoid maculopathy imaged with spectral domain OCT and autofluorescence
Journal article

Persistent placoid maculopathy imaged with spectral domain OCT and autofluorescence

Jaclyn L Kovach
Ophthalmic surgery, lasers & imaging, Vol.41 Suppl(6), pp.S101-103
2010-11
PMID: 21117593

Abstract

Choroidal Neovascularization - diagnosis Glucocorticoids - therapeutic use Retinal Diseases - diagnosis Administration, Oral Ophthalmic Solutions - administration & dosage Tomography, Optical Coherence Humans Male Retinal Pigment Epithelium - pathology Choroidal Neovascularization - drug therapy Cyclosporine - administration & dosage Aged Retinal Diseases - drug therapy Drug Therapy, Combination Immunosuppressive Agents - administration & dosage Prednisone - therapeutic use Triamcinolone Acetonide - administration & dosage Fluorescein Angiography
Persistent placoid maculopathy is a rare entity characterized by bilateral well-delineated whitish plaque-like lesions in the macula. Secondary choroidal neovascularization and extensive retinal pigment epithelial damage, highlighted by spectral domain optical coherence tomography and autofluorescence imaging, can limit visual prognosis. Aggressive immunosuppression can preserve vision and perhaps delay the onset of choroidal neovascularization.

Metrics

11 Record Views

Details